Clinical trials
Terminated Phase 3 Weight Loss trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 4 |
| 2008 | 1 |
| 2010 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Par Pharmaceutical, Inc. | 2 |
| Abbott | 1 |
| C. R. Bard | 1 |
| Immunotec Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Weight Loss | 7 |
| Obesity | 4 |
| Body Weight | 3 |
| Cachexia | 3 |
| Anorexia | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Insulin Resistance | 1 |
| Lung Neoplasms | 1 |
| Neoplasms | 1 |
| Pancreatic Neoplasms | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.